Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Amplification of MDM2 and CDK4 protooncogenes is common in human sarcomas.
• These amplifications may disrupt TP53 and retinoblastoma tumor suppressor protein (RB) pathways, affecting growth regulation.
• Inconsistent inclusion of MDM2 and CDK4 in observed amplicons suggested other factors might be involved.

Purpose of the Study:

• To investigate the involvement of 17 loci in the 12q13-15 region in sarcoma amplicons.
• To determine if MDM2 and CDK4 are co-selected during amplification or if other genes are involved.
• To explore alternative selection mechanisms in sarcomas with 12q13-15 amplifications.

Main Methods:

• Characterization of 17 loci within the 12q13-15 region.
• Analysis of amplicons in 21 sarcoma samples previously detected by comparative genomic hybridization.
• Assessment of amplification patterns for MDM2, CDK4, and intervening/nearby loci, including D12S8.

Main Results:

• Discrete amplicons were observed around MDM2 and CDK4, with reduced amplification of intervening sequences.
• This pattern suggests separate selection events for MDM2 and CDK4 amplification.
• The D12S8 locus, distal to MDM2, showed frequent amplification, including in a sample lacking MDM2 or CDK4 amplification.

Conclusions:

• Separate selection for MDM2 and CDK4 amplification is likely, making a single common selective gene improbable.
• Amplification of at least three distinct regions within the 12q13-15 segment (involving MDM2, CDK4, or a gene near D12S8) may be selected in tumor cells.
• These findings highlight complex genetic alterations in sarcoma development.